Industry · Healthtech

AI for healthtech decisions founders face

AI for healthtech decisions at the founder level: reimbursement strategy, regulatory pathway, payer vs provider GTM, clinical leadership hires, fundraising. Never medical, clinical, or patient-care advice.

Start free See how it works

In short

No. SynthBoard is built for founders making business decisions about healthtech companies — hiring, fundraising, GTM, regulatory strategy. It does not provide medical, clinical, diagnostic or treatment advice and is not a substitute for licensed clinicians.

Last reviewed October 1, 2026

An example

One ask, start to finish.
What comes back is a memo.

How a board takes a call like this: her read, who sits, what they ask first, then the call — with how sure they are, who disagreed and the first step.

Healthtech

Example · Board of 3

Should we pursue a 510(k) clearance, or stay positioned as a wellness product for now?

Chief of staff

This one needs a board: The Strategist, The Regulator and The Lawyer. The Strategist maps competitive dynamics and strategic options across multi-year horizons. Each researches alone first, then they react to one another — and on a decision, two of them take opposed sides.

The StrategistCompetitive Expert
The RegulatorCompliance Expert
The LawyerLegal Protector

Asked first

Has a competitor already made this move?

Yes, one hasNot that I knowWe’d be first

The board’s call

Stay in wellness positioning for 9 more months.

510(k) timing should follow your evidence, not your fundraising calendar. Two paid pilots beat one published study for payer conversations.

Confidence67 · Moderate

The Lawyer disagreed

“Wellness positioning has its own marketing-claim risks — keep legal review tight”

First step Use the runway to generate outcomes data with two enterprise pilots, then pursue 510(k) once the evidence supports it.this week

Board of 3 · up to 135 credits on the card · an example, not a recorded run

Other asks people bring here

Several asks in one message become several rooms, each with its expert and its own price on the card. Keep or drop any, then convene them together.

When do we hire our first Chief Medical Officer vs continue with clinical advisors? — The Regulator, up to 85 credits
Should we sell into health systems or pivot to a direct-to-payer motion? — The Lawyer, up to 85 credits
How do we price an enterprise contract with a 24-month sales cycle? — The CFO, up to 85 credits

What you get

What she handles.
On this kind of call.

Maps the regulatory pathway decision

510(k), De Novo, full PMA, or wellness-only positioning? The Regulator and The Strategist frame the trade-offs — strategic framing, not regulatory advice.

Stress-tests payer vs provider GTM

When do you sell to health systems, when to payers, when do you go DTC? Multi-year revenue patterns and ramp curves, argued by opposed experts on one board.

Frames clinical hiring & advisory decisions

When do you hire a Chief Medical Officer? What do you actually need from a clinical advisory board? The Empath and The Strategist work it through.

Pressure-tests fundraising for a long-cycle business

Healthtech is capital-intensive and slow. The CFO and The Investor argue the dilution math against the regulatory timeline.

Why SynthBoard

Why SynthBoard for this.
Not one voice. A board.

Strategic framing only — never medical advice

SynthBoard is for founder business decisions. It does not give medical, clinical, diagnostic or patient-care advice and is not a substitute for licensed clinicians, lawyers or regulatory consultants. Its experts are AI and can be wrong.

Built for the healthtech decision tempo

Long sales cycles, regulatory gates, payer negotiations. SynthBoard fits a business that makes its biggest decisions quarterly, not weekly.

Opposed views on a complex motion

The Regulator, The CFO, The Strategist and The Ethicist on one board, spread across different AI models — the trade-offs founders normally assemble across separate consulting engagements.

Who sits

The experts for this call.
Each one holds a position.

Your Chief of Staff proposes who sits for the call, and every board is built with someone whose job is to argue against the obvious answer. Name an expert and they take a seat; tell her who you want on your board and they sit by default. How many seats a board has depends on your plan.

Competitive Expert

The Strategist

Don’t ask whether it’s good. Ask what your competitor does the day after you ship it.

The Strategist Competitive Expert

Best on: Positioning, entering a market, pricing against a rival.
Won’t let you: Plan a move as if nobody will answer it.

Try asking The Strategist

Start with

The StrategistOpen on every plan, Free included

Pick an expert

Hover, tap or tab throughSwipe, then tap one

GPT
Claude
Gemini
Grok

Seats are spread across model families: GPT, Claude, Gemini, Grok and more.

In their words

The hardest healthtech decisions are not clinical — they are commercial. When to commit to the regulatory path, when to hire medical leadership, who to raise from. A board is where those trade-offs get argued before the cash burns.

The Strategist Competitive ExpertOn healthtech founder decisions

Questions

Fair questions.
Straight answers.

What people ask before they bring this call to a board.

Does SynthBoard give medical, clinical, or patient-care advice?

Will The Regulator replace my regulatory consultants?

No. The Regulator helps you frame the strategic shape of a regulatory decision — when to pursue clearance, what to weigh, what to ask. The submission and the primary-source compliance work stay with your specialist consultants and counsel.

Is this useful for digital therapeutics specifically, or only broader healthtech?

Both. DTx founders bring the FDA pathway decision, the reimbursement strategy and the clinical-evidence vs commercial-traction trade-off. Broader healthtech brings the same hiring, fundraising and GTM calls.

Can it model the impact of a CMS reimbursement change on my business?

Yes, as a strategic question. Describe the proposed or pending change in your own words and the board works through what it means for your model. It is not a reading of primary regulatory text — that is your healthcare counsel’s domain.

How does this fit alongside our clinical advisory board?

They are different instruments. Your clinical advisory board gives scientific and clinical guidance. SynthBoard argues the founder-level business decisions a clinical board is not set up for — pricing, partner selection, fundraising strategy.

Are my session contents HIPAA-protected?

No — do not put patient data in it. SynthBoard is built for founder strategy, not PHI (protected health information). Your rooms are private and encrypted at rest, but SynthBoard is not a HIPAA-covered entity or business associate.

SynthBoard (synthboard.ai) is one place for your business, your life, and every hard call. Your Chief of Staff keeps what you tell her on file, and 24 named experts on different AI models take the calls — one expert for a consult, a board with opposed seats for the hard ones — and hand back a memo with the call, the dissent and the first move. How it works.